Total of 104 patients were studied with an average age of 47.952 + 16.9112, with 77% of the patients being male. The maximum no of patient were of the middle aged adult males age group 31 -40.The study comprised of 104 individuals of which 79 patients were males and 25 were females. The average weight of the 104 patients was 68.615 kg .The body mass index of our patients had a mean of 26.146 with a minimum BMI of 14.382 a maximum BMI of 48.828.Forced expiratory volume in 1 st second in our OBESE asthmatics was 1.78 ± 0.8150.& Forced vital capacity in the obese group was 2.102 ± 0.8638 .FEV1% was > 70 % in all the patients of the study population demonstrating no fixed airflow limitation in patients of our study population . ERV in the obese groups was .441 ± 0.2190 liters. The inspiratory capacity in the obese group was 1.771 ± 0.6628 liters . No significant statistical correlation was demonstrated in between the obese and no obese group . Significant correlation was demonstrated between BMI & Waist Circumference.BMI correlated with FEV1, FVC, FEV1% in the study population and a negative correlation was demonstrable.A statistically significant co relation could not be established between BMI & the dynamic spirometric variables.BMI correlated with ERV & VC in the study population and a negative correlation was demonstrable.A statistically significant co relation could not be established between BMI & the static spirometric variables.Waist circumference correlated with the FEV1, FVC, FEV1% in the study population and a negative correlation was demonstrable. A statistically significant co relation could not be established between waist circumference & the dynamic spirometric variables. Waist circumference correlated with ERV & VC in the study population and a negative correlation was demonstrable. A statistically significant co relation could not be established between waist circumference & the static spirometric variables.
ABSTRACT:The epidemiologic evidence linking COPD and cardiovascular morbidity and mortality is strong. Even after adjustments for traditional cardiovascular risk factors such as serum total cholesterol hypertension, obesity and smoking, patients with COPD have a two-to threefold increase in the risk of cardiovascular events including death. Age >60 yrs
ABSTRACT:Bronchoscopy is an invasive test done with intention of diagnosing and treating complex pulmonary diseases. As a tertiary referral center in central India we received several such cases and analyzed 200 Bronchoscopy performed over 1 year. The indications of bronchoscopy are numerous and usually based on the presence of respiratory symptoms and abnormal chest radiograph or both. Common indications include peripheral pulmonary masses, hemoptysis, chronic cough, pleural effusion, recent or unresolved pneumonia, pulmonary tuberculosis, and lung collapse. In areas with high prevalence of pulmonary tuberculosis, bronchoscopy and bronchoscopic lung biopsy were found to be useful for diagnosis of pulmonary tuberculosis especially in the absence of radiological infiltration and negative sputum smears for acid fast bacilli. Several studies have shown that bronchoscopy is a safe procedure that carries very low mortality rate that ranges from 0% to 0.1%. KEYWORDS: Bronchoscopy.
AIMS AND OBJECTIVES:• To analyze the Indication, retrospectively with an intent to streamline and optimize our future performance and decrease patients morbidity & mortality.• To assess the safety of Fibre Optic Bronchoscopy Procedure • To correlate the Bronchoscopic findings with radiology and smoking status of the subjects.
MATERIALS AND METHODS:• Fiber optic Bronchoscope of Olympus make both adult and pediatric were used in local and
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.